Back to search
Adamantinous Craniopharyngioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adamantinous Craniopharyngioma trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Adamantinous Craniopharyngioma trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) Ju…
MEKTOVI (binimetinib) is an oral, highly selective reversible inhibitor of mitogen-activated extracellular signal regulated kinase 1 (MEK1) and MEK2. The biolog…